Tuesday, June 22, 2010
2:00 PM ET
SGS Webcast Series Part 2: Extractables and Leachables
Monomers and additives such as antioxidants, plasticizers, and stabilizers may potentially migrate into medicinal products and should be evaluated as required by regulatory authorities. Processing equipment as well as primary and secondary container materials must be considered. This webinar will highlight the changes affecting industry in the area of extractables and leachables testing, including a look at implementing ICH Q4B and global pharmacopeial differences between USP, JP, and Ph.Eur. requirements.

Tuesday, June 29, 2010
2:00 PM ET
SGS Webcast Series Part 3: Melamine and Contamination Challenges
This webinar will highlight the changes affecting industry in the area of melamine testing and related contamination issues, including recent FDA guidance, USP monographs, and international harmonization efforts.

Wednesday, June 23, 2010
11:00 AM ET
What Early Stage Companies Need to Know About Quality Management: Lessons Learned from Industry Leaders
What Early Stage Companies Need to Know About Quality Management: Lessons Learned from Industry Leaders Live Event Date/Time: June 23, 2010 at 11:00 AM EDT Life sciences companies are trying to cope with the mounting challenges of managing and maintaining quality systems while facing increased compliance risks. Clinical trials are becoming more complex and the FDA is scrutinizing data to a higher degree. This is leading to increased demands on quality organizations, and many are drowning in paper-based systems while struggling to maintain compliance. A panel of industry professionals will share, through a facilitated discussion, their experiences with deploying and realizing the benefits of QMS. They will discuss best practices they have implemented and lessons they have learned.

OnDemand
Topical Formulation Development and Screening
In this webcast we will help you understand the routes for drug penetration into human skin and the factors which dictate the penetration potential of a drug. You will learn about in vitro skin penetration models of normal and diseased skin for use in screening topical formulations.

Expansion of Vetter Development Service (VDS)
The North American market is critical to Vetter's strategic global growth as nearly half of its client base is already located here. In order to maximize on this opportunity, Vetter has decided to create a facility, its first outside of Germany, at the Illinois Science + Technology Park in suburban Chicago. The facility, which supports preclinical to phase II clinical batch projects, is an expansion of Vetter Development Service. With significant progress already having been made, the facility is scheduled to be operational by beginning of the fourth quarter 2010.

Operations Excellence Through Quality Management Software
Listen to Sparta Systems Industry Principal, Tim Mohn, discuss pressing issues that companies in the life science industry face. Ranging from the changing landscape of healthcare reform, to the expected ROI life science companies demand, Tim explores the benefits enterprise quality management software can deliver to help streamline processes and ensure quality and compliance across the supply chain.